In recent years, various biologics targeting specific inflammatory cytokines, such as IL-17A inhibitors, TNF-α inhibitors, IL-23 inhibitors, etc., have also been shown to be effective in treating psoriasis. This evidence concerns the gene TNF and psoriasis.